Beacon Pharmaceuticals (DHA:BEACONPHAR) Short-Term Debt : BDT7,657 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Beacon Pharmaceuticals Short-Term Debt?

Beacon Pharmaceuticals's Short-Term Debt for the quarter that ended in Dec. 2023 was BDT7,657 Mil.

Beacon Pharmaceuticals's quarterly Short-Term Debt increased from Jun. 2023 (BDT6,683 Mil) to Sep. 2023 (BDT6,895 Mil) and increased from Sep. 2023 (BDT6,895 Mil) to Dec. 2023 (BDT7,657 Mil).

Beacon Pharmaceuticals's annual Short-Term Debt increased from Jun. 2021 (BDT2,109 Mil) to Jun. 2022 (BDT3,629 Mil) and increased from Jun. 2022 (BDT3,629 Mil) to Jun. 2023 (BDT6,683 Mil).

Beacon Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Beacon Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beacon Pharmaceuticals Short-Term Debt Chart

Beacon Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Debt

Get a 7-Day Free Trial

1,210.57

1,688.39

2,109.46

3,629.07

6,682.83

Beacon Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															4,167.17	5,694.82	6,682.83	6,894.86	7,656.78

Beacon Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Beacon Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Beacon Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Beacon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beacon Pharmaceuticals PLC (DHA:BEACONPHAR) » Definitions » Short-Term Debt

Traded in Other Exchanges

N/A

Address

9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223

Website

https://www.beaconpharma.com.bd

Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.

Beacon Pharmaceuticals Headlines

No Headlines